gabanergic

(redirected from GABA-ergic)

gabanergic

(gab-ă-nĕr'jik),
Pertaining to the action of gamma aminobutyric acid (GABA) or to neural or metabolic pathways in which it functions as a transmitter.
Synonym(s): GABA-ergic, gabaergic
[GABA + G. ergon, work]
Farlex Partner Medical Dictionary © Farlex 2012
Mentioned in ?
References in periodicals archive ?
In the nematode Caenorhabditis elegans, where GABA also functions as a neuromuscular transmitter, genetic analyses have produced a deep understanding of inhibitory and excitatory GABA-ergic signaling (Jorgensen, 2005).
Lee, "Astrocytes as GABA-ergic and GABA-ceptive cells," Neurochemical Research, vol.
As GAD65 is located on both pancreatic islet cells and CNS gamma-amino-butyric acid (GABA-ergic) neurons, there is an association between GAD65 antibody positive CNS autoimmune disease and DM1.
Animal and neurobiology experiments have shown that schizophrenia is associated with genetic defects that involve changes of GABA-ergic neurons in the early stages of ontogeny.
[17] Protection of OS extract against PTZ induced seizure suggests a possible interaction with GABA-ergic neurotransmission indicating the presence of an anticonvulsant compound in the extract.
Other directions of research in the neurobiology of depression analyze factors such as: brain-derived nurotrophic factor, corticotropine-releasing factor and glucocorticoides, the estrogenic a and p receptors, colinergic and GABA-ergic transmission, neuroinflammation, and the opioide system.
GERMANTOWN, Md., January 11, 2016 -- Researchers have reported that Neuralstem, Inc.'s (CUR) HK532-IGF-1 cells differentiated into a subtype of neurons (GABA-ergic) that are dysregulated in Alzheimer's disease (AD) and produced increased vascular endothelial growth factors (VEGF) in vitro.
GERMANTOWN, Md., January 11, 2016 -- Researchers have reported that Neuralstem, Inc's (CUR) HK532-IGF-1 cells differentiated into a subtype of neurons (GABA-ergic) that are dysregulated in Alzheimer's disease (AD) and produced increased vascular endothelial growth factors (VEGF) in vitro.
GERMANTOWN, Md., January 11, 2016--Researchers have reported that Neuralstem, Inc.'s (CUR)HK532-IGF-1 cells differentiated into a subtype of neurons (GABA-ergic) that are dysregulated in Alzheimer's disease (AD) and produced increased vascular endothelial growth factors (VEGF) in vitro.
The mesolimbic DA system in the CNS is thought to play a prominent role in the development of drug reward and is strongly modulated by other neurotransmitter systems, including the opioidergic, glutamatergic, and a-aminobutyric acid (GABA-ergic) systems.